These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 18972565)

  • 1. COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome.
    Symoens S; Malfait F; Renard M; André J; Hausser I; Loeys B; Coucke P; De Paepe A
    Hum Mutat; 2009 Feb; 30(2):E395-403. PubMed ID: 18972565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients.
    Malfait F; Coucke P; Symoens S; Loeys B; Nuytinck L; De Paepe A
    Hum Mutat; 2005 Jan; 25(1):28-37. PubMed ID: 15580559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics in classic Ehlers-Danlos syndrome.
    Malfait F; De Paepe A
    Am J Med Genet C Semin Med Genet; 2005 Nov; 139C(1):17-23. PubMed ID: 16278879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refine diagnostic criteria.
    Symoens S; Syx D; Malfait F; Callewaert B; De Backer J; Vanakker O; Coucke P; De Paepe A
    Hum Mutat; 2012 Oct; 33(10):1485-93. PubMed ID: 22696272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural abnormalities of the cornea and lid resulting from collagen V mutations.
    Segev F; Héon E; Cole WG; Wenstrup RJ; Young F; Slomovic AR; Rootman DS; Whitaker-Menezes D; Chervoneva I; Birk DE
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):565-73. PubMed ID: 16431952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito.
    Toriello HV; Glover TW; Takahara K; Byers PH; Miller DE; Higgins JV; Greenspan DS
    Nat Genet; 1996 Jul; 13(3):361-5. PubMed ID: 8673139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome.
    Giunta C; Nuytinck L; Raghunath M; Hausser I; De Paepe A; Steinmann B
    Am J Med Genet; 2002 May; 109(4):284-90. PubMed ID: 11992482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.
    Malfait F; Symoens S; De Backer J; Hermanns-Lê T; Sakalihasan N; Lapière CM; Coucke P; De Paepe A
    Hum Mutat; 2007 Apr; 28(4):387-95. PubMed ID: 17211858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of binding partners interacting with the α1-N-propeptide of type V collagen.
    Symoens S; Renard M; Bonod-Bidaud C; Syx D; Vaganay E; Malfait F; Ricard-Blum S; Kessler E; Van Laer L; Coucke P; Ruggiero F; De Paepe A
    Biochem J; 2011 Jan; 433(2):371-81. PubMed ID: 20979576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel splice variant in the N-propeptide of COL5A1 causes an EDS phenotype with severe kyphoscoliosis and eye involvement.
    Symoens S; Malfait F; Vlummens P; Hermanns-Lê T; Syx D; De Paepe A
    PLoS One; 2011; 6(5):e20121. PubMed ID: 21611149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type.
    Malfait F; Wenstrup RJ; De Paepe A
    Genet Med; 2010 Oct; 12(10):597-605. PubMed ID: 20847697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced type I collagen utilization: a pathogenic mechanism in COL5A1 haplo-insufficient Ehlers-Danlos syndrome.
    Wenstrup RJ; Florer JB; Cole WG; Willing MC; Birk DE
    J Cell Biochem; 2004 May; 92(1):113-24. PubMed ID: 15095409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency.
    Schalkwijk J; Zweers MC; Steijlen PM; Dean WB; Taylor G; van Vlijmen IM; van Haren B; Miller WL; Bristow J
    N Engl J Med; 2001 Oct; 345(16):1167-75. PubMed ID: 11642233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ehlers-Danlos syndromes.
    Yeowell HN; Pinnell SR
    Semin Dermatol; 1993 Sep; 12(3):229-40. PubMed ID: 8217561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elastic fiber abnormalities in hypermobility type Ehlers-Danlos syndrome patients with tenascin-X mutations.
    Zweers MC; Dean WB; van Kuppevelt TH; Bristow J; Schalkwijk J
    Clin Genet; 2005 Apr; 67(4):330-4. PubMed ID: 15733269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygosity and Heterozygosity for Null Col5a2 Alleles Produce Embryonic Lethality and a Novel Classic Ehlers-Danlos Syndrome-Related Phenotype.
    Park AC; Phillips CL; Pfeiffer FM; Roenneburg DA; Kernien JF; Adams SM; Davidson JM; Birk DE; Greenspan DS
    Am J Pathol; 2015 Jul; 185(7):2000-11. PubMed ID: 25987251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Two Independent
    Bauer A; Bateman JF; Lamandé SR; Hanssen E; Kirejczyk SGM; Yee M; Ramiche A; Jagannathan V; Welle M; Leeb T; Bateman FL
    Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31546637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I.
    Takahara K; Schwarze U; Imamura Y; Hoffman GG; Toriello H; Smith LT; Byers PH; Greenspan DS
    Am J Hum Genet; 2002 Sep; 71(3):451-65. PubMed ID: 12145749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ehlers-Danlos syndromes and Marfan syndrome.
    Callewaert B; Malfait F; Loeys B; De Paepe A
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):165-89. PubMed ID: 18328988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI.
    Yeowell HN; Walker LC
    Mol Genet Metab; 2000; 71(1-2):212-24. PubMed ID: 11001813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.